MANJUSHA GAGLANI

Concepts (281)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Influenza Vaccines
105
2025
482
14.750
Why?
Influenza, Human
114
2025
662
14.480
Why?
Influenza A Virus, H1N1 Subtype
42
2024
178
6.890
Why?
Vaccination
88
2025
964
5.560
Why?
Influenza A Virus, H3N2 Subtype
47
2024
115
4.040
Why?
Seasons
51
2025
312
3.240
Why?
Hospitalization
58
2025
1790
3.110
Why?
Health Personnel
13
2022
509
2.450
Why?
Influenza B virus
29
2024
87
2.260
Why?
United States
106
2025
10936
1.910
Why?
Vaccines, Inactivated
23
2024
145
1.860
Why?
Antibodies, Viral
18
2025
1154
1.790
Why?
Adult
129
2025
29692
1.660
Why?
Emergency Responders
5
2022
17
1.480
Why?
Outpatients
17
2024
257
1.400
Why?
Respiratory Tract Infections
10
2023
274
1.320
Why?
Adolescent
90
2025
19373
1.310
Why?
Influenza A virus
13
2025
139
1.220
Why?
Humans
205
2025
125392
1.210
Why?
Population Surveillance
15
2025
389
1.140
Why?
Young Adult
59
2025
9069
1.110
Why?
Middle Aged
85
2025
26990
1.080
Why?
Aged
78
2025
19896
1.050
Why?
Vaccines, Combined
12
2024
39
1.010
Why?
Case-Control Studies
28
2025
3306
0.960
Why?
Viral Load
4
2023
389
0.960
Why?
Vaccines, Synthetic
16
2023
316
0.960
Why?
Child, Preschool
61
2025
14030
0.880
Why?
Prospective Studies
26
2025
6168
0.860
Why?
Vaccine Potency
6
2020
9
0.840
Why?
Male
98
2025
61663
0.820
Why?
Smallpox Vaccine
1
2023
37
0.810
Why?
Female
101
2025
66885
0.800
Why?
Ambulatory Care
11
2024
390
0.790
Why?
Antibody Formation
5
2024
266
0.730
Why?
Child
68
2025
24436
0.730
Why?
Spike Glycoprotein, Coronavirus
6
2025
188
0.730
Why?
Occupations
1
2021
22
0.720
Why?
Hemagglutination Inhibition Tests
6
2024
114
0.710
Why?
Occupational Diseases
1
2021
75
0.690
Why?
Respiratory Syncytial Virus Infections
4
2025
345
0.680
Why?
Infant
45
2025
12518
0.630
Why?
Pneumonia
1
2022
325
0.600
Why?
Immunocompromised Host
5
2024
294
0.590
Why?
RNA, Messenger
18
2024
2820
0.580
Why?
Vaccines, Attenuated
12
2018
175
0.550
Why?
Immunogenicity, Vaccine
3
2025
106
0.520
Why?
Dose-Response Relationship, Immunologic
1
2016
108
0.500
Why?
Dementia
1
2020
452
0.490
Why?
Immunization, Secondary
5
2022
104
0.480
Why?
Social Class
2
2013
190
0.480
Why?
Emergency Service, Hospital
12
2024
1070
0.470
Why?
Aged, 80 and over
23
2025
6607
0.440
Why?
Pandemics
5
2023
1115
0.410
Why?
Cohort Studies
12
2025
4824
0.410
Why?
Cell Culture Techniques
3
2024
281
0.410
Why?
Asthma
3
2008
756
0.400
Why?
Disease Outbreaks
4
2014
320
0.370
Why?
Hospital Mortality
7
2024
1026
0.360
Why?
Respiratory Syncytial Virus, Human
2
2023
207
0.350
Why?
Orthomyxoviridae
4
2014
51
0.350
Why?
Fever
1
2013
299
0.350
Why?
Attitude of Health Personnel
2
2013
677
0.350
Why?
Health Status Disparities
1
2013
228
0.350
Why?
Asymptomatic Infections
3
2025
34
0.350
Why?
Critical Illness
2
2023
601
0.300
Why?
Delivery of Health Care
3
2023
616
0.300
Why?
Patient Acuity
3
2025
66
0.290
Why?
Antiviral Agents
4
2022
767
0.290
Why?
Hemagglutinin Glycoproteins, Influenza Virus
2
2024
59
0.260
Why?
Retropharyngeal Abscess
2
1996
7
0.250
Why?
Administration, Intranasal
7
2010
132
0.250
Why?
Real-Time Polymerase Chain Reaction
4
2015
506
0.250
Why?
Respiration, Artificial
3
2023
473
0.230
Why?
Sentinel Surveillance
2
2024
19
0.220
Why?
Respiratory Syncytial Virus Vaccines
1
2025
70
0.220
Why?
Treatment Outcome
14
2025
12412
0.220
Why?
Presenteeism
2
2023
2
0.220
Why?
Bias
1
2024
133
0.220
Why?
Alkanesulfonic Acids
1
2023
10
0.220
Why?
Respiratory Tract Diseases
2
2020
75
0.210
Why?
Drug Utilization
2
2015
161
0.210
Why?
Molecular Diagnostic Techniques
2
2015
153
0.210
Why?
Acute Disease
5
2018
1111
0.210
Why?
Fluorocarbons
1
2023
56
0.210
Why?
Environmental Pollutants
1
2023
68
0.210
Why?
Self Report
4
2023
517
0.200
Why?
RNA, Viral
5
2023
538
0.190
Why?
Venous Thromboembolism
1
2025
167
0.190
Why?
Intention
1
2022
93
0.190
Why?
Bronchial Hyperreactivity
1
2001
38
0.190
Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2018
1290
0.190
Why?
Health Knowledge, Attitudes, Practice
2
2025
854
0.190
Why?
Immunoglobulin G
1
2024
777
0.190
Why?
Firefighters
1
2022
32
0.190
Why?
Age Factors
8
2020
2827
0.180
Why?
Reminder Systems
1
2001
60
0.180
Why?
Middle East Respiratory Syndrome Coronavirus
1
2021
22
0.180
Why?
Carrier State
1
2021
76
0.180
Why?
Liver Diseases
1
2025
368
0.180
Why?
Vaccination Coverage
4
2023
35
0.180
Why?
Research Design
1
2025
695
0.180
Why?
Coinfection
1
2022
172
0.170
Why?
Organ Transplantation
1
2022
168
0.170
Why?
Sick Leave
1
2020
5
0.170
Why?
Hospitals
4
2024
398
0.170
Why?
Viral Vaccines
1
2023
337
0.170
Why?
Severity of Illness Index
5
2022
2917
0.170
Why?
Antigenic Variation
1
2020
39
0.170
Why?
Mycobacterium marinum
1
1999
1
0.160
Why?
Oregon
3
2014
9
0.160
Why?
Cheek
1
1999
27
0.160
Why?
Incidence
6
2025
3154
0.160
Why?
Immunity, Herd
4
2024
12
0.160
Why?
Vaccines
1
2024
366
0.160
Why?
Mycobacterium Infections, Nontuberculous
1
1999
46
0.150
Why?
Drug Prescriptions
2
2018
221
0.150
Why?
Body Mass Index
1
2024
1568
0.150
Why?
Specimen Handling
2
2022
142
0.150
Why?
Inappropriate Prescribing
1
2018
41
0.150
Why?
Abscess
1
1999
137
0.140
Why?
Pregnancy Complications, Infectious
1
2022
455
0.140
Why?
Antibody Specificity
2
2013
204
0.140
Why?
Enterococcus faecalis
1
1997
47
0.140
Why?
Immunization Schedule
3
2022
102
0.140
Why?
Gram-Positive Bacterial Infections
1
1997
76
0.140
Why?
Laboratories
3
2021
81
0.130
Why?
Mental Disorders
1
2024
829
0.130
Why?
Texas
6
2013
3589
0.130
Why?
Office Visits
2
2015
77
0.130
Why?
Washington
2
2013
32
0.130
Why?
Diagnostic Self Evaluation
2
2013
21
0.130
Why?
Accidents, Home
1
1996
9
0.130
Why?
Pulmonary Disease, Chronic Obstructive
1
2023
604
0.130
Why?
Foot Injuries
1
1996
7
0.130
Why?
Mediastinal Emphysema
1
1996
11
0.130
Why?
Pneumonia, Aspiration
1
1996
18
0.130
Why?
Medication Errors
1
2018
187
0.130
Why?
Cost of Illness
1
2017
252
0.130
Why?
Immunization
3
2023
308
0.120
Why?
Antibodies, Bacterial
1
1997
390
0.120
Why?
Time Factors
5
2025
6345
0.120
Why?
Efficiency
1
2015
62
0.120
Why?
Antibodies, Neutralizing
3
2025
470
0.120
Why?
Neutrophils
1
1997
381
0.120
Why?
Surveys and Questionnaires
5
2022
3741
0.120
Why?
Anti-Bacterial Agents
4
2020
2433
0.110
Why?
Immunity, Humoral
2
2024
71
0.110
Why?
Osteomyelitis
1
1996
208
0.110
Why?
Clostridium Infections
1
1996
245
0.100
Why?
Risk Factors
6
2025
10331
0.100
Why?
Anemia, Sickle Cell
1
1996
331
0.100
Why?
Streptococcal Infections
1
1995
240
0.100
Why?
Logistic Models
3
2025
1815
0.100
Why?
Practice Patterns, Physicians'
2
2018
735
0.100
Why?
Schools
1
2014
219
0.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2019
734
0.100
Why?
Hepatitis A Antibodies
1
2011
9
0.100
Why?
Hepatitis A Vaccines
1
2011
10
0.090
Why?
Chickenpox Vaccine
1
2011
13
0.090
Why?
Measles-Mumps-Rubella Vaccine
1
2011
14
0.090
Why?
Odds Ratio
3
2020
1260
0.090
Why?
Health Status
1
2013
377
0.090
Why?
History, 21st Century
3
2017
264
0.090
Why?
Bayes Theorem
2
2022
285
0.080
Why?
Heart Failure
1
2023
2299
0.080
Why?
Oxygen
2
2023
557
0.080
Why?
Reference Standards
2
2021
236
0.080
Why?
Genetic Variation
1
2016
1502
0.080
Why?
Sex Factors
1
2013
1289
0.080
Why?
RNA
2
2023
570
0.080
Why?
Nose
2
2020
94
0.070
Why?
Respiratory Sounds
1
2008
70
0.070
Why?
Oropharynx
2
2020
34
0.070
Why?
Comorbidity
2
2019
1537
0.070
Why?
Parents
2
2024
1026
0.060
Why?
Chronic Disease
2
2022
1201
0.060
Why?
Epitopes, B-Lymphocyte
1
2025
31
0.060
Why?
Drainage
2
1996
259
0.050
Why?
Immunologic Memory
1
2025
190
0.050
Why?
Risk
2
2017
758
0.050
Why?
Propensity Score
1
2025
222
0.050
Why?
Respiratory Syncytial Viruses
1
2024
147
0.050
Why?
Advisory Committees
1
2024
152
0.050
Why?
RNA-Directed DNA Polymerase
1
2022
46
0.050
Why?
Nucleoproteins
1
2022
25
0.050
Why?
Dyspnea
1
2024
152
0.050
Why?
Community-Acquired Infections
1
2005
241
0.050
Why?
RNA, Messenger, Stored
1
2022
7
0.050
Why?
Fatigue
1
2024
190
0.050
Why?
Police
1
2022
9
0.050
Why?
Perception
1
2024
220
0.050
Why?
B-Lymphocytes
1
2025
535
0.050
Why?
Risk Assessment
2
2021
3468
0.050
Why?
Drugs, Investigational
1
2002
22
0.050
Why?
Epitopes
1
2024
433
0.050
Why?
Arizona
1
2021
23
0.050
Why?
Antibodies
1
2023
374
0.050
Why?
Immunocompetence
1
2022
32
0.050
Why?
Neutralization Tests
1
2022
235
0.050
Why?
Computer Simulation
1
2025
653
0.050
Why?
Saliva
1
2022
114
0.050
Why?
Nasopharynx
2
2013
79
0.050
Why?
Child, Hospitalized
1
2022
73
0.050
Why?
Safety
1
2002
217
0.050
Why?
Documentation
1
2022
113
0.050
Why?
Sample Size
1
2021
86
0.040
Why?
Proteomics
1
2024
502
0.040
Why?
Longitudinal Studies
1
2025
1329
0.040
Why?
Absenteeism
2
2014
20
0.040
Why?
Demography
1
2021
240
0.040
Why?
Whole Genome Sequencing
1
2022
281
0.040
Why?
Transplant Recipients
1
2022
219
0.040
Why?
Diagnosis, Differential
2
1996
1899
0.040
Why?
Sensitivity and Specificity
2
2016
2058
0.040
Why?
Syndrome
1
2022
1121
0.040
Why?
Workplace
1
2020
70
0.040
Why?
Retrospective Studies
3
2024
16389
0.040
Why?
Pharyngitis
1
2018
32
0.040
Why?
Patient Acceptance of Health Care
1
2022
427
0.040
Why?
School Health Services
2
2010
99
0.040
Why?
Public Health Surveillance
1
2018
38
0.040
Why?
Blood Bactericidal Activity
1
1997
17
0.040
Why?
Opsonin Proteins
1
1997
20
0.040
Why?
Patient Readmission
1
2021
385
0.040
Why?
Medical Records
1
2018
192
0.040
Why?
Immunologic Factors
1
2019
174
0.040
Why?
Intensive Care Units
1
2021
493
0.040
Why?
Complement System Proteins
1
1997
58
0.040
Why?
Frailty
1
2019
104
0.030
Why?
Clinical Trials as Topic
1
2002
1104
0.030
Why?
Inpatients
1
2021
500
0.030
Why?
Immunization Programs
1
2017
63
0.030
Why?
Pharynx
1
2017
66
0.030
Why?
Sinusitis
1
2018
116
0.030
Why?
Phagocytosis
1
1997
170
0.030
Why?
Antimicrobial Stewardship
1
2018
84
0.030
Why?
Prevalence
1
2023
2467
0.030
Why?
Pregnancy
2
2022
7223
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1698
0.030
Why?
Genetic Drift
1
2016
21
0.030
Why?
Cross-Sectional Studies
1
2025
3440
0.030
Why?
Tibia
1
1996
70
0.030
Why?
Fusarium
1
1996
11
0.030
Why?
Electronic Health Records
1
2023
722
0.030
Why?
Bacillus
1
1996
35
0.030
Why?
Amphotericin B
1
1996
90
0.030
Why?
Health Services
2
2006
71
0.030
Why?
Topography, Medical
1
2015
6
0.030
Why?
Antigens, Bacterial
1
1997
314
0.030
Why?
Disease Progression
1
2021
2077
0.030
Why?
Cross Protection
1
2014
7
0.030
Why?
Polymerase Chain Reaction
1
2018
1586
0.030
Why?
Linear Models
1
2016
686
0.030
Why?
Escherichia coli Infections
1
1996
189
0.030
Why?
Infant, Newborn
2
2017
8240
0.030
Why?
Radiography
1
1996
823
0.030
Why?
Antifungal Agents
1
1996
291
0.030
Why?
Nasal Cavity
1
2013
50
0.030
Why?
Self-Assessment
1
2013
66
0.030
Why?
Obesity
1
2024
2252
0.030
Why?
Drug Therapy, Combination
1
1996
1175
0.020
Why?
Activities of Daily Living
1
2014
407
0.020
Why?
Combined Modality Therapy
1
1995
1244
0.020
Why?
Recurrence
1
1995
1420
0.020
Why?
Follow-Up Studies
1
2020
5185
0.020
Why?
Drug Interactions
1
2011
257
0.020
Why?
High-Throughput Nucleotide Sequencing
1
2016
880
0.020
Why?
Vaccines, Subunit
1
2010
66
0.020
Why?
Age Distribution
1
2010
419
0.020
Why?
Placebos
1
2010
241
0.020
Why?
Internet
1
2012
376
0.020
Why?
Skin Diseases
1
2010
130
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2010
259
0.020
Why?
Injections, Intramuscular
1
2007
194
0.020
Why?
Tomography, X-Ray Computed
1
1995
2107
0.020
Why?
Double-Blind Method
1
2010
1638
0.020
Why?
Family Health
1
2006
259
0.020
Why?
Michigan
1
2005
42
0.010
Why?
Japan
1
2005
133
0.010
Why?
Registries
1
2010
1435
0.010
Why?
GAGLANI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (281)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_